Sign In
Buy LLY
$1,131.42
+6.04 (+0.537%)
At Close: Jun 05, 2026
Shed the Fat, Gain the Profits: 3 Weight-Loss Stocks to Own Until 2027
06:25am, Friday, 12'th Apr 2024
Weight-loss stocks remain the focus of many investors. The GLP-1 drugs that many companies have put forward address key health concerns like obesity and diabetes, which have become epidemics in many W
Wall Street Favorites: 3 Healthcare Stocks With Strong Buy Ratings for April 2024
04:30pm, Thursday, 11'th Apr 2024
Healthcare's impact on the economy cannot be overstated. According to the American Medical Association, the U.S. spends more than $4 trillion a year on healthcare, which works out to nearly $13,000 pe
Trillion-Dollar Trajectories: 3 Billion-Dollar Stocks With the Potential to Hit the Next Milestone
03:55pm, Thursday, 11'th Apr 2024
Reaching the trillion-dollar market cap is a testament to any company's international influence, massive customer base and brand power. Indeed, being considered a peer of global behemoths like Microso
Eli Lilly (LLY) Increases Despite Market Slip: Here's What You Need to Know
06:51pm, Wednesday, 10'th Apr 2024
Eli Lilly (LLY) reachead $761.98 at the closing of the latest trading day, reflecting a +0.63% change compared to its last close.
This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives?
09:27am, Wednesday, 10'th Apr 2024
A new exchange-traded fund needs an edge to attract investors. This might be its industry focus — a tall order in a crowded market with ETFs covering just about any industry you can imagine.
Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.
06:35am, Tuesday, 09'th Apr 2024
Eli Lilly wowed patients and investors with its top-performing weight loss drugs. The big pharma company's stock has climbed in the triple digits over the past year thanks to its revenue growth.
This 1 Number May Ensure Eli Lilly's Dominance in the Weight Loss Drug Market
06:30am, Monday, 08'th Apr 2024
Eli Lilly's weight loss drugs are generating billions of dollars in revenue. The company continues to develop candidates that may result in even better products.
Could This New Development Soon Buoy Eli Lilly and Novo Nordisk Stock?
07:15am, Sunday, 07'th Apr 2024
Novo Nordisk and Eli Lilly make medicines that target GLP-1, which figures in a number of ailments. A new study found that a similar drug could help treat Parkinson's.
Wegovy's heart benefits are not just linked with weight loss, new study suggests
04:16pm, Saturday, 06'th Apr 2024
People with obesity-related heart failure and diabetes can get substantial heart-health benefits from the popular obesity drug Wegovy, even if they don't shed a lot of weight on the medication, accord
Eli Lilly's Wegovy Competitor Is Causing Supply Constraints: What It Means for the Stock
08:30am, Saturday, 06'th Apr 2024
Eli Lilly is having trouble keeping up with the demand for Zepbound. This medicine could go on to break sales records.
3 Growth Stocks with Even Greater Potential Than the Magnificent 7
09:33am, Thursday, 04'th Apr 2024
We're at a crossroads in this current market. Tech and growth stocks continue to soar while undervalued stocks lag.
Diabetes medication appears to slow progress of Parkinson's disease in French-backed trial
07:12am, Thursday, 04'th Apr 2024
A Type 2 diabetes medication called lixisenatide appeared to slow the progression of Parkinson's disease symptoms in a small, mid-stage trial funded by the French Ministry of Health and others, the Ne
Could This 1 Detail Help Viking Therapeutics Top Eli Lilly and Novo Nordisk in the Weight Loss Drug Market?
04:55am, Thursday, 04'th Apr 2024
Eli Lilly and Novo Nordisk have seen demand surpass supply of their weight loss drugs. Their revenues have soared thanks to these popular products.
Why Eli Lilly Stock Topped the Market Today
04:31pm, Wednesday, 03'rd Apr 2024
A prognosticator upgraded his recommendation on the healthcare giant. He says it is now worthy of a buy.
The 3 Best Healthcare Stocks to Buy in April 2024
04:09pm, Wednesday, 03'rd Apr 2024
The recent uptick in U.S. manufacturing signals a promising trend for the economy. Investor confidence in the economy's stability is reflected in the decreasing odds for a June rate cut, indicating op
